BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 692281)

  • 1. Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection.
    Fields JZ; Reisine TD; Yamamura HI
    Life Sci; 1978 Aug; 23(6):569-73. PubMed ID: 692281
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of kainic acid on striatal dopamine receptors.
    Weinreich P; Seeman P
    Brain Res; 1980 Oct; 198(2):491-6. PubMed ID: 7407614
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations of muscarinic cholinergic receptors in the rat striatum after kainic acid injections.
    Hruska RE; Schwarcz R; Coyle JT; Yamamura HI
    Brain Res; 1978 Sep; 152(3):620-5. PubMed ID: 687979
    [No Abstract]   [Full Text] [Related]  

  • 4. Histofluorescence of kainic acid-induced striatal lesions.
    Meibach RC; Brown L; Brooks FH
    Brain Res; 1978 Jun; 148(1):219-23. PubMed ID: 656926
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
    Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
    Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
    [No Abstract]   [Full Text] [Related]  

  • 6. Kainic acid lesions decrease striatal dopamine receptors and 1,4-dihydropyridine sites.
    Skattebøl A; Hruska RE; Hawthorn M; Triggle DJ
    Neurosci Lett; 1988 Jun; 89(1):85-9. PubMed ID: 2456499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circling behavior following unilateral kainic acid injections into rat striatum.
    Taylor RJ; Reavill C; Jenner P; Marsden CD
    Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of endogenous level, uptake and release of taurine after intrastriatal kainic acid injection.
    Placheta P; Singer E; Schönbeck G; Heckl K; Karobath M
    Neuropharmacology; 1979 Apr; 18(4):399-402. PubMed ID: 450205
    [No Abstract]   [Full Text] [Related]  

  • 14. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
    Minneman KP; Quik M; Emson PC
    Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
    Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
    Zahniser NR; Minneman KP; Molinoff PB
    Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
    Braszko JJ; Bannon MJ; Bunney BS; Roth RH
    J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.